Equities research analysts at Wedbush boosted their FY2028 earnings per share estimates for shares of Chimerix in a research note issued on Tuesday, February 18th. Wedbush analyst D. Nierengarten now ...

Wedbush upped their FY2025 earnings estimates for shares of CarMax in a research report issued to clients and investors on ...

Alibaba's shares opened 10% higher in Hong Kong on Friday to reach their highest level in more than three years, after it reported third-quarter ...

Palantir Technologies, Inc. (PLTR) stock has pulled back about 15% since it hit an all-time closing high of $124.62 on ...

We recently compiled a list of the Top 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a ...

Palantir shares continued to decline on Thursday, extending a sharp sell-off. The stock fell nearly 9%, following Wednesday’s ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

After defying gravity for the past couple of years, Palantir Technologies ( PLTR -5.17%) has finally hit turbulence, with the ...

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here’s ...

U.S. defense stocks opened in the red on Thursday, Feb. 20 following reports that President Donald Trump’s administration has ...

Palantir Technologies received a new Buy rating from Loop Capital and continued bullish support from Wedbush on Thursday, despite recent market concerns over potential U.S. defense budget cuts.

Wedbush reiterated its outperform rating on TSLA with a $550 price target, representing a 55.08% increase from the current ...